Echocardiography application in patients with COVID‑19
https://doi.org/10.33667/2078-5631-2022-11-41-46
Abstract
The article highlights the experience of ultrasound and functional diagnostics imaging doctor’s work in the «red zone» at the time of new COVID‑19 coronavirus infection pandemic. Echocardiography is a valuable tool in the assessment of right ventricular disfunction and pulmonary hypertension degree, acute virus myocarditis and acute coronary syndrome. Transthoracic and transesophageal echocardiography is used to monitor the patient’s condition during treatment with extracorporeal membrane oxygenation (ECMO) and multiple organ failure syndrome.
About the Authors
N. V. Rybalko
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
Rybalko Natalia V., DM Sci (habil.), leading researcher at Dept of Radiation Diagnostics
Moscow
L. T. Khamidova
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
Khamidova Layla T., DM Sci (habil.), head of Dept of Radiation Diagnostics
Moscow
V. M. Abuchina
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
Abuchina Vera M., physician at Dept of Ultrasound Diagnostics
Moscow
S. S. Petrikov
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation
Russian Federation
Petrikov Sergey S., Corresponding Member of RAS, DM Sci (habil.), professor, director of ‘N.V. Sklifosovsky Research Institute for Emergency Medicine’, head of Dept of Anesthesiology, Resuscitation and Emergency Medicine at ‘A.I. Evdokimov Moscow State Medical University’
Moscow
References
1. WHO Director-General’s opening remarks at the media briefing on COVID‑19–3 May 2021. https://www.who.int/director-general/speeches/detail/directorgeneral-s-opening-remarks-at-the-media-briefing-on-covid-19-3-may-2021 (Accessed December 27, 2021).
2. Ministry of Health of the Russian Federation. Prevention, diagnosis and treatment of novel coronavirus infection (COVID‑19): interim guidelines. Version 13.1 (11/17/2021). Moscow; 2021.
3. Zheng YY, Ma YT, Zhang JY, Xie X. COVID‑19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260. https://doi.org/10.1038/s41569–020–0360–5
4. He XW, Lai JS, Cheng J, Wang MW, Liu YJ, Xiao ZC, et al. Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID‑19 patients. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(6):456–460. https://doi.org/10.3760/cma.j.cn112148–20200228–00137
5. Salem R, Vallee F, Rusca M, Mebazaa A. Hemodynamic monitoring by echocardiography in the ICU: the role of the new echo techniques. Curr Opin Crit Care. 2008;14(5):561–568. https://doi.org/10.1097/MCC.0b013e32830e6d81
6. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. https://doi.org/10.1093/eurheartj/ehz405
7. Schmiady MO, Sromicki J, Kucher N, Ouda A. Successful percutaneous thrombectomy in a patient with COVID‑19 pneumonia and acute pulmonary embolism supported by extracorporeal membran oxygenation. Eur Heart J. 2020;41(32):3107. https://doi.org/10.1093/eurheartj/ehaa403
8. Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, et al. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2020;66(7):707–721. https://doi.org/10.1097/MAT.0000000000001193
9. Osho AA, Moonsamy P, Hibbert KA, Shelton KT, Trahanas JM, Attia RQ, et al. Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID‑19 Patients: Early Experience from a Major Academic Medical Center in North America. Ann Surg. 2020;272(2): e75-e78. https://doi.org/10.1097/SLA.0000000000004084
10. Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and Proposed Management of the Acute COVID‑19 Cardiovascular Syndrome. Circulation. 2020;141(23):1903–1914. https://doi.org/10.1161/CIRCULATIONAHA.120.047349
11. Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis – diagnosis, treatment options and current controversies. Nat Rev Cardiol. 2015;12(11):670–680. https://doi.org/10.1038/nrcardio.2015.108
12. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID‑19). JAMA Cardiol. 2020;5(7):819–824. https://doi.org/10.1001/jamacardio.2020.1096
13. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV‑2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475–481. https://doi.org/10.1016/S2213–2600(20)30079–5
14. Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak. J Am Coll Cardio. 2020;75(24):3078–3084. https://doi.org/10.1016/j.jacc.2020.04.002
15. Bagate F, Masi P, d’Humières T, Al-Assaad L. Advanced echocardiographic phenotyping of critically ill patients with coronavirus‑19 sepsis: a prospective cohort study. Journal of Intensive Care. 2021; 9(12)
16. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus disease 2019 (COVID‑19) and cardiovascular disease. Circulation. 2020;141(20):1648–1655.
17. Valente S, Anselmi F, Cameli M. Acute coronary syndromes during COVID‑19. Eur Heart J. 2020;41(22):2047–2049. https://doi.org/10.1093/eurheartj/ehaa457
18. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID‑19). JAMA Cardiol. 2020;5(7):811–818. https://doi.org/10.1001/jamacardio.2020.1017
Review
For citations:
Rybalko N.V., Khamidova L.T., Abuchina V.M., Petrikov S.S. Echocardiography application in patients with COVID‑19. Medical alphabet. 2022;(11):41-46. (In Russ.) https://doi.org/10.33667/2078-5631-2022-11-41-46
Views:
286
Email this article 